Positioning no disclosures inside 60 days, left as found
Options put/call open interest 7.34, read 2026-11-07
Ethical passes the values gate
Price134.36 USD
Fair value182.24
Ethical score70.0/100
Value readUndervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-11-05Read Markup143.40-6.3% to today Accumulation gives way to Markup after an 8% rise in 8 days
2026-10-28Read Accumulation132.91+1.1% to today ✓Markdown gives way to Accumulation
2026-10-27Read Markdown132.91+1.1% to today Accumulation gives way to Markdown first Markdown read since October
2026-10-23Read Accumulation132.91+1.1% to today ✓Markdown gives way to Accumulation with results news in the headlines
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Oshkosh Corporation holds its Markup at $134.36. Consolidating, no directional conviction, held for 96 days.
As held on the ledger · 2026-11-06
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 96 days
Price at the screen
$134.36
Valuation
18.13 trailing · 11.00 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.27
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
10.93%
Below 33%
Interest-bearing debt is just 10.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
19.22%
Below 49%
Money owed to the company is 19.2% of assets, under the 49% limit.
Pass
Revenue purity
0.08%
Below 5%
Only 0.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Oshkosh clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 11%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when OSK's ethical verdict changes
Today OSK passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Conscience flag · AFSC Investigate, American Friends Service Committee, Don’t Buy Into Occupation, Palestinian BDS National Committee, Who Profits Corporate Database
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Documented on AFSC Investigate / American Friends Service Committee / Don’t Buy Into Occupation / Palestinian BDS National Committee / Who Profits Corporate Database — category: Corporate Complicity Report / Annex 2 Company List. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 6 Nov 2026: it trades at roughly a 26% discount to our $182.24 fair value, 5.70% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 26.3% discount to the base estimate.
Where our models see it going: fair-value estimate $182.24, with a range of $182.24 to $268.72, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Construction kit maker stuck in neutral
Picture a fleet of cherry pickers and military trucks parked up on a building site. When the economy is booming they earn their keep, yet right now Oshkosh is running flat. Revenue is flat, margins sit at six percent and return on equity reaches only thirteen percent, so the business is not compounding.
At 10.3 times forward earnings the shares look inexpensive against a fair value thirty seven percent higher, yet zero top line growth flags a classic cyclical trap. Peak earnings often arrive with low multiples precisely because the next downturn is already on the way. The ethical screen clears, which is welcome, but that alone does not turn a mature industrial into a compounder.
Seventeen analysts still lean buy with a median target above the current price, yet construction and vocational demand swing hard with interest rates and government budgets. Currency moves and order delays add further lumps. Without visible growth the discount may simply be fair compensation for the cycle. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
OSK trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markup · changed$143.40+4.0%Entry 17
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $165. Since the last review it its composite score eased.
2026-10-29Accumulation$137.93+3.8%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markdown · changed$132.91+0.0%Entry 14
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Accumulation$132.91+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$132.91+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$132.91+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markdown$132.91+3.3%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 3.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $165. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markdown$128.71-1.6%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $165.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
